ITP Registry and Accompanying Biospecimen Collection

NCT05152238 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1100

Last updated 2025-07-15

No results posted yet for this study

Summary

The objective of this ITP registry is to collect clinical information, including biosampling, from consenting patients with a variety of ITPs at different points in the course of their disease.

Conditions

Sponsors & Collaborators

  • University Hospital Dresden

    collaborator OTHER
  • Novartis

    collaborator INDUSTRY
  • Swedish Orphan Biovitrum

    collaborator INDUSTRY
  • Grifols Biologicals, LLC

    collaborator INDUSTRY
  • Amgen

    collaborator INDUSTRY
  • argenx

    collaborator INDUSTRY
  • Jena University Hospital

    lead OTHER

Principal Investigators

  • Thomas Stauch, Dr. med. · Jena University Hospital

  • Karolin Trautmann-Grill, Dr. med. · Dresden Univeristy Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-29
Primary Completion
2026-09-30
Completion
2027-04-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05152238 on ClinicalTrials.gov